Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

EpilepsyGTx has partnered with ClearPoint Neuro to support the targeted [...]

A Phase 1/1b clinical trial has begun in Australia to [...]

ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]

Autolomous and Cellular Origins have integrated their manufacturing platforms to [...]

Autolomous and Cellular Origins have integrated their platforms to create [...]

Bio-Rad Laboratories has launched a portfolio of Vericheck ddPCR kits [...]

Genespire and researchers at the San Raffaele Telethon Institute for [...]

Cyllene Therapeutics has raised €33 million in a Series C [...]

Vect-Horus has entered a research collaboration and exclusive licence option [...]